Sendai virus-based immunoadjuvant in hydrogel vaccine intensity-modulated dendritic cells activation for suppressing tumorigenesis
The conventional immunoadjuvants in vaccine have weak effect on stimulating antigen presentation and activating anti-tumor immunity. Unexpectedly, we discovered that non-pathogenic Sendai virus (SeV) could activate antigen-presenting cells (APCs) represented by dendritic cells (DCs). Here, we design...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
KeAi Communications Co., Ltd.
2021-11-01
|
| Series: | Bioactive Materials |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2452199X21001596 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|